Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 19

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 19
---
 Our                                                                                           
 directors, management and shareholders may from time to time be subject to negative publicity 
 or claims, controversies, lawsuits, other legal and administrative proceedings and fines,     
 which could have a material adverse effect on our business, results of operations, financial  
 condition and reputation. See more detailed discussion of this risk factor on page 23         
 of this prospectus.                                                                           |

| ● | We                                                                                                
 rely on proprietary information, such as trade secrets and know-how. See more detailed discussion 
 of this risk factor on page 23 of this prospectus.                                                |

| ● | We                                                                                           
 may be accused of infringing intellectual property rights of others and content restrictions 
 of relevant laws. See more detailed discussion of this risk factor on page 24                
 of this prospectus.                                                                          |

| ● | The                                                                                       
 proper functioning of our information technology systems is essential to our business. We 
 may fail to maintain the satisfactory performance of our systems.  See more detailed      
 discussion of this risk factor on page 24 of this prospectus.                             |

| ● | Our                                                                                       
 business generates, collects and processes a large quantity of data, and any improper use 
 or disclosure of or unauthorized access to such data may harm our reputation. See more    
 detailed discussion of this risk factor on page 24 of this prospectus.                    |

| ● | We                                                                                              
 may be subject to complaints, claims, controversies, regulatory actions, arbitrations and       
 legal proceedings from time to time. If the outcome of these complaints, claims, controversies, 
 regulatory actions, arbitrations and legal proceedings is adverse to us, it could have a        
 material adverse effect on our business, results of operations, financial condition, liquidity, 
 cash flows and reputation. See more detailed discussion of this risk factor on page 25          
 of this prospectus.                                                                             |

| ● | A                                                                                        
 lack of insurance could expose us to significant costs and business disruption. See more 
 detailed discussion of this risk factor on page 25 of this prospectus.                   |

| ● | Our                                                                                           
 financial and operating performance may be adversely affected by epidemics, natural disasters 
 and other catastrophes. See more detailed discussion of this risk factor on page 25           
 of this prospectus.                                                                           |

<div align='center'>4</div>

Risks Related to Our Corporate Structure We are also subject to risks and uncertainties related to our corporate structure, including, but not limited to, the following:

| ● | Our                                                                                          
 directors and officers currently own a significant percentage